OTC Markets OTCPK - Delayed Quote USD
Affimed N.V. (AFMDQ)
0.0780
-0.0040
(-4.88%)
At close: June 12 at 8:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -1.27 | -7.09 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in EUR | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -1.61 | -1.58 | -1.02 | -0.95 |
| EPS Actual | -6.52 | -1.27 | -1.01 | -0.94 |
| Difference | -4.91 | 0.31 | 0.01 | 0.01 |
| Surprise % | -304.97% | 19.81% | 0.81% | 1.40% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 2 | 2 | -- |
| Up Last 30 Days | -- | 2 | 2 | -- |
| Down Last 7 Days | -- | 1 | 1 | -- |
| Down Last 30 Days | -- | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AFMDQ | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.43% | 7.54% | 14.06% |
Upgrades & Downgrades
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 5/14/2025 |
| Downgrade | Wells Fargo: Overweight to Equal-Weight | 5/13/2025 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 5/13/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 12/12/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
Related Tickers
ADAP Adaptimmune Therapeutics plc
0.2423
-1.46%
BYSI BeyondSpring Inc.
2.7900
-1.41%
ONCO Onconetix, Inc.
4.7300
-24.90%
ABP Abpro Corporation
0.2150
-11.85%
FATE Fate Therapeutics, Inc.
1.2750
-8.93%
LPTX Leap Therapeutics, Inc.
0.4099
-2.91%
PRQR ProQR Therapeutics N.V.
1.8800
-3.09%
CASI CASI Pharmaceuticals, Inc.
1.8400
+1.71%
SPRC SciSparc Ltd.
0.3210
-1.05%
TRAW Traws Pharma, Inc.
1.6900
-6.11%